New oral drugs for the treatment of multiple sclerosis

被引：0
作者：
Chard, Declan [1 ,2 ,3 ]
Trip, Anand [1 ,2 ,3 ]
Chataway, Jeremy [1 ,2 ,3 ,4 ]
机构：
[1] UCL Inst Neurol, Queen Sq Multiple Sclerosis Ctr, Dept Neuroinflammat, London WC1N 3BG, England
[2] Univ Coll London Hosp, Natl Inst Hlth Res Biomed Res Ctr, London, England
[3] UCL, London, England
[4] UCL Inst Neurol, Neurol, London, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2016年 / 77卷 / 09期
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; NATALIZUMAB; TRIAL;
D O I：
10.12968/hmed.2016.77.9.502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：502 / 503
页数：2
相关论文
共 10 条
  • [1] [Anonymous], 2016, DACL TREAT REL REM M
  • [2] Progressive multifocal leukoencephalopathy in patients with multiple sclerosis
    Baldwin, Kelly J.
    Hogg, Jeffery P.
    [J]. CURRENT OPINION IN NEUROLOGY, 2013, 26 (03) : 318 - 323
  • [3] Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
    Chataway, Jeremy
    Schuerer, Nadine
    Alsanousi, Ali
    Chan, Dennis
    MacManus, David
    Hunter, Kelvin
    Anderson, Val
    Bangham, Charles R. M.
    Clegg, Shona
    Nielsen, Casper
    Fox, Nick C.
    Wilkie, David
    Nicholas, Jennifer M.
    Calder, Virginia L.
    Greenwood, John
    Frost, Chris
    Nicholas, Richard
    [J]. LANCET, 2014, 383 (9936) : 2213 - 2221
  • [4] European Medicine Agency, 2015, NEW REC MIN RISKS RA
  • [5] European Medicines Agency, 2015, UPD REC MIN RISK RAR
  • [6] Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group
    McGuigan, C.
    Craner, M.
    Guadagno, J.
    Kapoor, R.
    Mazibrada, G.
    Molyneux, P.
    Nicholas, R.
    Palace, J.
    Pearson, O. R.
    Rog, D.
    Young, C. A.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (02) : 117 - 125
  • [7] Montalban X, 2015, MULT SCLER J, V21, P781
  • [8] National Institute for Health and Care Excellence, 2014, DIM FUM TREAT REL RE
  • [9] National Institute for Health and Care Excellence, 2012, FING TREATM HIGHL AC
  • [10] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
    Polman, CH
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Toal, M
    Lynn, F
    Panzara, MA
    Sandrock, AW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) : 899 - 910
1